Mark C. Hagan - 17 Feb 2022 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Role: Chief Information and Digital
Signature: /s/ Mark C. Hagan
Issuer symbol: AMN
Transactions as of: 17 Feb 2022
Net transactions value: -$371,851
Form type: 4
Filing time: 22 Feb 2022, 17:45:36 UTC
Previous filing: 19 Jan 2022
Next filing: 07 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMN	Common Stock	Award	$0	+7,798	+72%	$0.000000	18,612	17 Feb 2022	Direct	F1
transaction	AMN	Common Stock	Tax liability	$371,851	-3,867	-21%	$96.16	14,745	17 Feb 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested.
F2	Number of shares withheld for tax purposes.

Content

The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested.

Number of shares withheld for tax purposes.